Skip to content

To compare the quality of recovery in patients of osteoarthritis of knee joint using continuous neuroablative radiofrequency with that of pulsed neuromodulative radiofrequency procedure under Xray guidance

Comparison of the efficacy of fluoroscopic guided continuous neuroablative versus pulsed neuromodulative radiofrequency of genicular nerves in patients of osteoarthritis knee - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072701
Enrollment
40
Registered
2024-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M171- Unilateral primary osteoarthritisof knee

Interventions

Intervention1: continuous neuroablative radiofrequency (CNARF): The CNARF therapy employs higher frequency alternating current by specially designed needles to induce thermal lesions using dedicated r

Sponsors

Government Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Chronic knee pain of moderate to greater intensity with VAS score more than 3 for more than 3 months 2.Patients with radiological based Kellgren and Lawrence Grade 2, 3 and 4 osteoarthritis knee.

Exclusion criteria

Exclusion criteria: 1. Patients with acute knee pain 2. Patients with history of prior knee surgery 3. Patient with severe heart, lung, hepatic, renal, psychiatric, neurological, connective tissue disorder, uncontrolled diabetes mellites or hypertension 4. Patients who received intra articular knee injections with steroid or hyaluronic acid within last three months 5. Severe bleeding diathesis or on anticoagulation therapy 6. Patient with temporary or permanent cardiac pacemaker 7. Presence of systemic infection or local infection at the injection site 8. Significant allergic reaction or hypersensitivity to contrast, anaesthetic, or corticosteroids 9. Patient diagnosed with other malignancy 10. Patient on uncontrollable or unstable opioid use

Design outcomes

Primary

MeasureTime frame
To compare the analgesic efficacy of CNARF versus PNMRF using visual analogue scale (VAS) in patients of osteoarthritis knee.Timepoint: Pain assessment of patient by VAS score at pre-intervention, 1, 2 and 3 month postintervention.

Secondary

MeasureTime frame
1. Comparison of functional improvement achieved by CNARF versus PNMRF using Western Ontario McMaster Universities‘ (WOMAC) index of osteoarthritis. 2. Comparison of participants satisfaction achieved by CNARF versus PNMRF using five point Likert scale.Timepoint: 1.Functional improvement of the patient assessed by WOMAC score at pre-intervention, 1, 2 and 3 month post-intervention. 2.Patient satisfaction level by Likert five point scale at pre-intervention, 1, 2 and 3 month post-intervention.

Countries

India

Contacts

Public ContactDr Dheeraj Kapoor

Government Medical College and Hospital Sector 32 Chandigarh

Kapoor.dheeraj72@gmail.com9646121549

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026